VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,284,523 | -33.9% | 605,907 | -3.7% | 0.00% | – |
| Q2 2023 | $1,944,494 | +607.1% | 629,286 | +1131.2% | 0.00% | – |
| Q1 2023 | $274,988 | -58.6% | 51,113 | -48.8% | 0.00% | – |
| Q4 2022 | $663,842 | +304.8% | 99,826 | +142.2% | 0.00% | – |
| Q3 2022 | $164,000 | -20.0% | 41,213 | 0.0% | 0.00% | – |
| Q2 2022 | $205,000 | -88.0% | 41,213 | -85.4% | 0.00% | – |
| Q1 2022 | $1,710,000 | -44.5% | 283,076 | +6.7% | 0.00% | – |
| Q4 2021 | $3,081,000 | -16.8% | 265,185 | +12.3% | 0.00% | – |
| Q3 2021 | $3,702,000 | -1.6% | 236,123 | +17.0% | 0.00% | – |
| Q2 2021 | $3,764,000 | -48.5% | 201,803 | +19.0% | 0.00% | – |
| Q1 2021 | $7,307,000 | – | 169,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |